Common use of Forecast and Planning Clause in Contracts

Forecast and Planning. Bioverativ shall submit to Biogen written, rolling forecasts for planning and purchase of Drug Substance, Drug Product and Finished Goods supply needs, in accordance with the template attached on Schedule 5 attached hereto, itemized as follows: Clinical Drug Substance 1-7 8-19 20–60 Quarterly Commercial Drug Substance 1-13 14-25 26-60 Quarterly Clinical and Commercial Active Drug Product & Diluent 1-7 8-16 17-60 Monthly Finished Goods 1-4 N/A 5-24 Monthly (i) The “Binding Forecast” shall be binding per the terms noted above for the quantities of clinical and commercial DS Batches or Active Drug Product and Diluent or Finished Goods, respectively, by Presentation forecasted for future orders by Bioverativ for release in the months specified above, with “month-one” of such Binding Forecast representing the month during which such Forecast is submitted.